TRISOMY-21, FETAL HYDROPS, AND ANEMIA - PRENATAL-DIAGNOSIS OF TRANSIENT MYELOPROLIFERATIVE DISORDER

Citation
Sk. Hendricks et al., TRISOMY-21, FETAL HYDROPS, AND ANEMIA - PRENATAL-DIAGNOSIS OF TRANSIENT MYELOPROLIFERATIVE DISORDER, Obstetrics and gynecology, 82(4), 1993, pp. 703-705
Citations number
9
Categorie Soggetti
Obsetric & Gynecology
Journal title
ISSN journal
00297844
Volume
82
Issue
4
Year of publication
1993
Part
2
Pages
703 - 705
Database
ISI
SICI code
0029-7844(1993)82:4<703:TFHAA->2.0.ZU;2-#
Abstract
Background: Aneuploidy is frequently cited as an etiology of hydrops f etalis. Traditionally, associated anomalies (specifically cardiovascul ar abnormalities) have been postulated as the causative factor. Cases: We report two cases of severe anemia associated with hydrops in fetus es that later proved to have Down syndrome. The hematocrit in both fet uses was markedly decreased. The white blood cell count was normal in one but greatly elevated in the other; the latter infant had thrombocy topenia. These findings are consistent with transient myeloproliferati ve disorder. Conclusions: Nonimmune fetal hydrops and trisomy 21 may b e associated without cardiac or anatomical anomalies. Transient myelop roliferative disorder has been seen in neonates with trisomy 21 and ma y be a cause of hydrops in some aneuploid fetuses. Chromosomal analysi s should not be excluded in the workup of nonimmune hydrops when anemi a is found, and therapy may be withheld until karyotyping has been per formed.